Bruno Delafont

Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial

Michael Roden, Jianping Weng, Jens Eilbracht et al. · The Lancet Diabetes & Endocrinology · 2013 · 438 citations

Diabetes Management, Cardiovascular Disease, Medicine +8

Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis

Stephen I. Rennard, Nicholas Locantore, Bruno Delafont et al. · Annals of the American Thoracic Society · 2015 · 152 citations

PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma

Antoni Ribas, Alain P. Algazi, Paolo A. Ascierto et al. · Nature Communications · 2020 · 85 citations · Full text

Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies

Lucia Carboni, Dennis J. McCarthy, Bruno Delafont et al. · Translational Psychiatry · 2019 · 76 citations · Full text

Distinct Modulatory Effects of Satiety and Sibutramine on Brain Responses to Food Images in Humans: A Double Dissociation across Hypothalamus, Amygdala, and Ventral Striatum

Paul C. Fletcher, Antonella Napolitano, Andrew Skeggs et al. · Journal of Neuroscience · 2010 · 73 citations · Full text